✧
✦
✧
🇪🇺   EU SIXTH FRAMEWORK PROGRAMME INITIATIVE

Pharma-Planta Consortium

Advancing Molecular Farming for Next-Generation Plant-Made Pharmaceuticals

Exploring plant biotechnology, recombinant protein production, biosafety and GMP-compliant manufacturing platforms for biopharmaceutical innovation.

Discover the Project → Explore Research
About Pharma-Planta

A European Pioneer in Plant-Based Pharmaceutical Production

The Pharma-Planta Consortium was one of Europe's ambitious collaborative research initiatives dedicated to the development of plant-based pharmaceutical production.

Supported through the European Union Sixth Framework Programme, the consortium brought together universities, biotechnology organizations and industrial partners to establish an integrated production pipeline for recombinant pharmaceutical proteins in genetically engineered plants.

Its work connected molecular biology, plant biotechnology, recombinant protein expression, biosafety assessment, manufacturing quality standards and regulatory science.

Learn About the Mission →
Green plant biotechnology and molecular farming research
Molecular Farming | Plant Biotechnology | Recombinant Proteins
EU FP6 European Research Framework
2011 Phase I Clinical Trial Milestone
GMP Manufacturing Standards
Plant-Based Recombinant Protein Research
Scientific Research & Innovation

The Science Behind Molecular Farming

Discover the scientific disciplines that contributed to the development of plant-based pharmaceutical production systems.

🌱

Molecular Farming

Investigating the use of genetically engineered plants as biological production systems for recombinant proteins and complex biomolecules.

🧬

Plant-Made Pharmaceuticals

Exploring plant-derived recombinant proteins, molecular expression systems and plant-based biopharmaceutical production technologies.

🔬

Recombinant Protein Production

Studying protein expression, molecular characterization, purification and quality assessment in plant-based production platforms.

🛡️

Biosafety Assessment

Examining containment strategies, environmental safety, biological risk assessment and regulatory requirements for genetically modified plants.

⚙️

GMP Manufacturing

Exploring Good Manufacturing Practice requirements, production quality systems, process validation and controlled manufacturing environments.

🧪

Clinical Development

Understanding the transition from laboratory research and preclinical evaluation to regulated clinical development of plant-derived candidates.

Integrated Production Platform

From Plant Engineering to Pharmaceutical Production

An integrated molecular farming pipeline connects genetic engineering, recombinant expression, purification, quality assessment and regulated development.

01

Gene Design

Design and preparation of genetic constructs for recombinant expression.

02

Plant Transformation

Introduction of genetic information into suitable plant expression systems.

03

Protein Expression

Production and expression of target recombinant proteins in plants.

04

Purification & QC

Protein recovery, purification and analytical quality assessment.

05

GMP Development

Controlled manufacturing, quality systems and regulatory development.

Plant biotechnology research and controlled plant cultivation
Our Scientific Mission

Building the Foundations of Molecular Farming

The mission of Pharma-Planta was to advance Europe as a leading research environment for molecular farming by developing reliable and safe production platforms for recombinant pharmaceutical proteins in plants.

Its scientific programme extended from fundamental plant molecular biology to production development, biosafety, regulatory science and clinical evaluation.

  • Advance plant-based recombinant protein expression.
  • Develop scalable molecular farming platforms.
  • Establish biosafety and environmental assessment approaches.
  • Integrate GMP manufacturing and quality standards.
  • Support regulatory and clinical development pathways.
Scientific Milestone

From Molecular Research to Clinical Development

Pharma-Planta advanced the scientific and regulatory development of plant-derived pharmaceutical proteins beyond laboratory investigation. Its programme culminated in a Phase I human clinical trial in 2011, demonstrating an important milestone in the development of plant-made pharmaceuticals.

This work contributed to broader scientific discussions surrounding molecular farming, plant-based expression systems, biosafety and the potential of plants as production platforms for complex recombinant proteins.

Life Science Research Distribution Partner

Supporting Biotechnology Research with Gentaur

Gentaur is the distribution partner for life science research products, providing researchers and laboratories with access to scientific resources across molecular biology, plant biotechnology, recombinant protein research and related laboratory applications.

Explore a broad portfolio of antibodies, ELISA kits, laboratory reagents, molecular biology products and biotechnology research resources.

Explore Gentaur Research Products →
Plant Biotechnology • Molecular Innovation

Exploring the Future of Plant-Made Pharmaceuticals

Discover the science, technologies and research approaches behind molecular farming, recombinant protein production, plant biotechnology and next-generation biopharmaceutical manufacturing.

Explore Scientific Research →
BEST PRICES

Best Prices for Life Science Research

Discover competitive prices on antibodies, ELISA kits, laboratory reagents and biotechnology research products.

DISCOVER GENTAUR →
Your research. Our scientific resources.